Laura M. Spring MD
- Breast medical oncologist at the Massachusetts General Hospital Cancer Center
Laura M. Spring, MD, is a breast medical oncologist at the Massachusetts General Hospital Cancer Center. She completed her oncology fellowship at the Dana-Farber Cancer Institute and Massachusetts General Hospital Cancer Center through the Partners CancerCare Fellowship Program at Harvard Medical School, after she finished her internal medicine residency at Brigham & Women’s Hospital. Dr. Spring seeks to develop and lead clinical trials of novel therapies that focus on improving outcomes for people with breast cancer.
Types of chemotherapy
Chemotherapy medicines are put into classes based on how they affect substances inside the cancer cell, which process or activity the medicine affects in the cancer cell, and what specific point the medicine attacks a cell as it rests, grows or divides.
Common regimens (for early stage breast cancer)
There are many different types of chemotherapy medicines. These may be given alone, called single-agent therapy. But in many cases, a combination of two or more medicines, called a regimen, are given together or in sequence to treat early-stage breast cancer.
Vinorelbine (Navelbine) is a chemotherapy medicine made from the periwinkle plant that belongs to the family of plant agents called vinca alkaloids. It is a type of microtubule inhibitor chemotherapy. It is typically used to treat metastatic breast cancer.